Genmab — Oktober 2017
-
if you look at reuters for example on JNJ
, it is "New cancer drugs help J&J top profit estimates" http://uk.reuters.com/article/us-johnson-johnson-results/new-cancer-drugs-help-jj-top-profit-estimates-idUKKBN1CM1CN?feedType=RSS&feedName=healthNews&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FUKHealthNews+(News+%2F+UK+%2F+Health+News) -
Nej den kommer ikke i 1500 i år. Du må vente på forhåbentlig gode data i solide tumorer
-
Indtil videre er den steget ca. 15% i år. det er OK for mig. Har været med siden kurs 35,00, og har oplevet være ting end det idag. Op med humøret. Ja Genmab er lige pludselig over 1500,00, men om det bliver i år, kan jeg ikke udtale mig om, men jeg er sikker på den gør det. Op med humøret, det kan ikke bare altid gå op.
-
Som EL postede forleden: Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.http://www.biopharminternational.com/jj-invests-biologic-manufacturing-capacity-expansion-ireland-0
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
